R&D Center

HLB PHARMA

Platform technology &
Research Pipeline

R&D CenterPlatform technology &
Research Pipeline

Platform technology for Long-acting injections:

  • Manufacturing system

    • Automatic process control
    • Real-time process monitoring
    • CIP/SIP function
    • Automatic record generation

  • Manufacturing Process

    • Continuous manufacturing process
    • Excellent reproducibility
    • High production yield

  • Final Products

    • Controllable drug release
    • Uniform particle size
    • High drug encapsulating efficiency

Platform technology

Technology Development stage
Establish a Platform technology Lab scale Scale up for clinical trials Scale up for commercialization
Long-acting injectable formulation tech (Uniform microspheres). (SMEB®)
Biomaterial modification tech. and its related DDS platform for subcutaneous injection of Biologics
 

Products

Products Code Indication Phase
Fomulation Preclinical Clinical Registration and market launch
Long-acting injection HLBP-024 Thrombosis
 
HLBP-013 Parkinson's disease
     
HLBP-037 Alzheimer’s disease
   
HLBP-038 Obesity&Diabetes
   
Biomaterials based products HLBP-040 Functional Filler
   

Government-funded Research Projects

Program Project Name Goverment Department Periods
Advanced Technology Center (ATC+) Development of domestic microfluidic devices and real time process analysis technology for more than 10g/h of medicine production. Ministry of Trade, Industry and Energy 2022.04~2025.12
SME Technological Innovation R&D Development of sustained-release uniform microspheres and their mass production technology for the treatment of metabolic steatohepatitis Ministry of SMEs and Startups 2024.10~2026.09